DrugPatentWatch – Make Better Decisions

Follow DrugPatentWatch – Make Better Decisions
Share on
Copy link to clipboard

Business Intelligence on Biologic and Small Molecule Drugs

DrugPatentWatch


    • Jul 30, 2024 LATEST EPISODE
    • weekdays NEW EPISODES
    • 225 EPISODES


    Search for episodes from DrugPatentWatch – Make Better Decisions with a specific topic:

    Latest episodes from DrugPatentWatch – Make Better Decisions

    Benefits of Drug Patent Licensing Agreements

    Play Episode Listen Later Jul 30, 2024


    The Power of Patent Licensing: Unlocking Innovation and Access to Medicines Patent licensing agreements have become a crucial tool in […] Source

    Enforcing Your Drug Patent: Innovative Strategies

    Play Episode Listen Later Jul 29, 2024


    In the fiercely competitive pharmaceutical industry, securing and enforcing patents is crucial for recouping the massive investments required to bring […] Source

    The Role of Patient Advocacy Groups in Generic Drug Development

    Play Episode Listen Later Jul 28, 2024


    Patient advocacy groups have become increasingly influential in the pharmaceutical industry, particularly in the development of generic drugs. These groups, […] Source

    The Impact of International Trade Agreements on Drug Patents: A Systematic Review

    Play Episode Listen Later Jul 28, 2024


    The Agreement on Trade-Related Aspects of Intellectual Property Rights (TRIPS) sets minimum standards for intellectual property protection globally, including patents […] Source

    Is Chiral Switching Still Relevant in Today’s Pricing Control Scenario?

    Play Episode Listen Later Jul 26, 2024


    Chiral switching, the practice of developing a single enantiomer from a previously approved racemic drug, has been a significant strategy […] Source

    How to Develop a Competitive Edge in Generic Drug Development

    Play Episode Listen Later Jul 25, 2024


    Developing a competitive edge in generic drug development is crucial for companies to gain a significant market share and dominate […] Source

    How to Find Key Starting Materials (KSMs) for Pharmaceutical APIs

    Play Episode Listen Later Jul 25, 2024


    To identify Key Starting Materials (KSMs) for Active Pharmaceutical Ingredients (APIs), pharmaceutical companies and regulatory bodies follow a systematic approach […] Source

    How to Navigate the Generic Drug Market Post-COVID

    Play Episode Listen Later Jul 25, 2024


    The generic drug market has been significantly impacted by the COVID-19 pandemic, with both challenges and opportunities arising from the […] Source

    The Regulatory Maze: How Generic Drugs Navigate FDA Approval

    Play Episode Listen Later Jul 24, 2024


    In the high-stakes world of pharmaceuticals, generic drugs have become the unsung heroes of healthcare accessibility. These cost-effective alternatives to […] Source

    Drafting Detailed Drug Patent Claims: The Art and Science of Pharmaceutical IP Protection

    Play Episode Listen Later Jul 24, 2024


    In the high-stakes world of pharmaceutical innovation, drafting detailed drug patent claims is a critical process that can make or […] Source

    Biologic Product Hopping: Innovation or Market Manipulation?

    Play Episode Listen Later Jul 24, 2024


    As patents expire on blockbuster biologic drugs, manufacturers are increasingly employing a controversial tactic known as “product hopping” to maintain […] Source

    The Chiral Switch: A Pharmaceutical Tactic to Prolong Exclusivity

    Play Episode Listen Later Jul 23, 2024


    Enantiomer Switching: A Pharmaceutical Strategy to Extend Drug Patents Enantiomer switching, also known as chiral switching, is a strategy employed […] Source

    Cracking the Biosimilar Code: A Deep Dive into Effective IP Strategies

    Play Episode Listen Later Jul 22, 2024


    In the rapidly evolving landscape of biosimilars, intellectual property (IP) strategy is paramount. Biosimilar manufacturers face unique challenges, including navigating […] Source

    Understanding the Patent Trial and Appeal Board (PTAB) – A Comprehensive Overview

    Play Episode Listen Later Jul 21, 2024


    Introduction The Patent Trial and Appeal Board (PTAB) is a crucial component of the United States Patent and Trademark Office […] Source

    How to Transition to a New CDMO Smoothly

    Play Episode Listen Later Jul 18, 2024


    Transitioning to a new Contract Development and Manufacturing Organization (CDMO) can be a complex and challenging process. However, by following […] Source

    Winning Drug Patent Disputes: Proven Strategies for Pharmaceutical Companies

    Play Episode Listen Later Jul 17, 2024


    The High Stakes of Pharmaceutical Patent Litigation In the fiercely competitive pharmaceutical industry, patent disputes can make or break a […] Source

    Navigating Patent Opposition in Drug Patenting: A Comprehensive Guide

    Play Episode Listen Later Jul 16, 2024


    Introduction Patent oppositions are a crucial tool in the pharmaceutical industry, allowing civil society to challenge the validity of patents […] Source

    The Complexity Advantage: Why Advanced Delivery Methods Deter Generic Competition

    Play Episode Listen Later Jul 15, 2024


    The Strategic Advantage of Complex Drug Delivery Systems In the highly competitive pharmaceutical landscape, adopting complex drug delivery systems can […] Source

    Rx for Change: How Nonprofit Pharma is Reshaping the Industry

    Play Episode Listen Later Jul 15, 2024


    An HHS report titled “The Potential Role of The Nonprofit Pharmaceutical Industry in Addressing Shortages and Increasing Access to Essential […] Source

    CDMO Value Proposition: Why It Matters

    Play Episode Listen Later Jul 11, 2024


    The value proposition of Contract Development and Manufacturing Organizations (CDMOs) has become increasingly crucial in the pharmaceutical industry. As the […] Source

    Biosimilar Patent Dance: Leveraging PTAB Challenges for Strategic Advantage

    Play Episode Listen Later Jul 11, 2024


    In the high-stakes world of biosimilar development, manufacturers are increasingly turning to an unexpected partner: the Patent Trial and Appeal […] Source

    Viagra’s Resilience in the Face of Generic Competition: A Pharmaceutical Market Analysis

    Play Episode Listen Later Jul 10, 2024


    This is an example from the DrugPatentWatch AI Research Assistant, which is available with DrugPatentWatch subscriptions. The DrugPatentWatch AI Research […] Source

    The impact of biosimilars on biologic drug distribution models

    Play Episode Listen Later Jul 9, 2024


    The introduction of biosimilars has significantly altered the landscape of biologic drug distribution models. Biosimilars, which are highly similar to […] Source

    Unified Patent Court Reshapes European Patent Landscape

    Play Episode Listen Later Jul 9, 2024


    In a seismic shift for European intellectual property, the Unified Patent Court (UPC) is rapidly transforming how businesses approach patent […] Source

    How to find low-competition generic drug opportunities

    Play Episode Listen Later Jul 9, 2024


    To find low-competition generic drug opportunities, focus on drugs with limited competition due to small patient populations, complex formulations, or […] Source

    Patenting Drugs Developed with Artificial Intelligence: Navigating the Legal Landscape

    Play Episode Listen Later Jul 8, 2024


    The integration of artificial intelligence (AI) into drug discovery and development is revolutionizing the pharmaceutical industry. AI's ability to analyze […] Source

    China Leads in AI-Driven Drug Discovery Patents, Signaling Pharmaceutical Innovation Boom

    Play Episode Listen Later Jul 6, 2024


    China is emerging as a global frontrunner in patenting artificial intelligence (AI) technologies for drug discovery, particularly in the field […] Source

    The Power of Patience: Delaying Patents to Enhance Pharma Market Exclusivity

    Play Episode Listen Later Jul 2, 2024


    The pharmaceutical industry is a high-stakes arena where innovation, investment, and intellectual property (IP) protection intersect. One of the most […] Source

    How can pharmaceutical marketing evolve with generic entry? The example of Lipitor

    Play Episode Listen Later Jul 1, 2024


    Lipitor's marketing strategy underwent a significant evolution as generic competition emerged, employing aggressive tactics to retain market share and brand […] Source

    DrugPatentWatch Week in Review

    Play Episode Listen Later Jun 29, 2024


    Patent Expirations and Generic Competition This week saw several major blockbuster drugs facing patent expirations, potentially opening the market for […] Source

    Best Practices for Drug Patent Portfolio Management

    Play Episode Listen Later Jun 27, 2024


    Introduction Patent portfolios are critical assets for pharmaceutical companies, providing market exclusivity and protecting revenue streams for drug products. Effective management of drug patent portfolios requires strategic planning, ongoing evaluation, and adaptation to the evolving pharmaceutical landscape. This article explores key best practices for optimizing drug patent portfolios to maximize value and maintain competitive advantage. […] Source

    What is the market forecast for Ozempic?

    Play Episode Listen Later Jun 26, 2024


    This is an example from the DrugPatentWatch AI Research Assistant, which is available with DrugPatentWatch subscriptions. The DrugPatentWatch AI Research Assistantuses sophisticated AI algorithms to understand and process your questions, delivering precise answers. It goes beyond simple keyword matching, comprehending the intent and context of questions to provide meaningful and relevant responses. Learn more at […] Source

    The Double-Edged Sword: Opportunities and Challenges in China’s Patent Litigation System

    Play Episode Listen Later Jun 26, 2024


    Introduction In the rapidly evolving landscape of pharmaceutical patent disputes in China, injunctive relief has emerged as a critical tool for patent holders. This legal remedy, which aims to halt infringement activities swiftly, plays a pivotal role in protecting intellectual property (IP) rights and fostering innovation. As China's pharmaceutical market continues to grow, understanding the […] Source

    Introducing DrugChatter: Revolutionizing Information Access

    Play Episode Listen Later Jun 25, 2024


    DrugChatter is an innovative AI-powered search and answer engine designed to revolutionize how we access and comprehend information. Harnessing the power of advanced natural language processing, DrugChatter provides concise, accurate, and contextually relevant answers to a wide array of questions, making information retrieval faster and more intuitive than ever before. What Makes DrugChatter Unique? Use […] Source

    USPTO Study Reveals Trends and Insights into Drug Patent and Exclusivity Trends in the Pharmaceutical Industry

    Play Episode Listen Later Jun 25, 2024


    Introduction: The United States Patent and Trademark Office (USPTO) has recently released a comprehensive study on drug patents and exclusivity trends in the pharmaceutical industry. The report, titled “USPTO Drug Patent and Exclusivity Study Report,” provides valuable insights into the patent landscape, patent duration, and exclusivity trends that shape the pharmaceutical industry. As a business […] Source

    Leveraging 505(b)(2) to Innovate Beyond Existing Drug Patents

    Play Episode Listen Later Jun 24, 2024


    The 505(b)(2) regulatory pathway provides an attractive avenue for drug developers to bring new products to market by leveraging existing data on approved drugs. This pathway allows modifications and improvements to be made to existing drugs, while potentially reducing development costs and timelines compared to the traditional new drug application (NDA) route. Here are some […] Source

    The Intricate Journey of Drug Patents: From Filing to Expiry

    Play Episode Listen Later Jun 20, 2024


    In the high-stakes world of pharmaceuticals, patents play a pivotal role in safeguarding intellectual property and ensuring a return on investment for drug developers. The journey of a drug patent is a complex and intricate one, spanning from the initial filing to its eventual expiry. This article delves into the nuances of this process, shedding […] Source

    Uncovering Lucrative Low-Competition Generic Drug Opportunities

    Play Episode Listen Later Jun 19, 2024


    In the ever-evolving pharmaceutical landscape, savvy businesses are constantly on the lookout for untapped markets and lucrative opportunities. One area that has garnered significant attention is the realm of low-competition generic drugs. These are off-patent medications that, for various reasons, have yet to attract a significant number of generic manufacturers, creating a potential goldmine for […] Source

    Maximizing ROI with Branded Generics: A Comprehensive Guide

    Play Episode Listen Later Jun 18, 2024


    Branded generics are generic drugs that are marketed under a brand name by the manufacturer. These products contain the same active ingredients as their brand-name counterparts but are typically sold at a lower price point. Branded generics can be an attractive option for both consumers and pharmaceutical companies, offering cost savings while leveraging brand recognition. […] Source

    A Practical Guide to FtO Analysis for Drug Repurposing Ventures

    Play Episode Listen Later Jun 17, 2024


    A recent whitepaper by Hermann Mucke summarizes the steps to performing an FTO for drug repurposing: Overview An FtO analysis determines if a new product or process can proceed without infringing third-party intellectual property (IP) rights, especially patents. It is crucial for drug repurposing projects involving known compounds that may still be patent-protected. Basic Principles […] Source

    Divisional Patent Minefields: Navigating Big Pharma’s Patent Extension Strategies

    Play Episode Listen Later Jun 17, 2024


    The article “The devil is in the divisional: an analysis of divisional patents, deadlines, declarations and suggestions for future practice” by Mieke Filler provides a comprehensive analysis of the strategic use of divisional patents in the pharmaceutical sector to delay generic and biosimilar market entry. Key Points Citations:[1] https://academic.oup.com/jiplp/advance-article/doi/10.1093/jiplp/jpae046/7693785[2] https://www.bakerbotts.com/thought-leadership/publications/2021/october/on-the-interface-of-intellectual-property-and-antitrust[3] https://www.bakerbotts.com/~/media/files/thought-leadership/publications/2021/october/medicines-for-europe-position-paper-on-divisional-patents-mar-20211.pdf?hash=82CB8F9CFD49A2B2099711E363E79DD6E00B46F9&la=en[4] https://www.aipla.org/list/innovate-articles/revisiting-divisional-patent-applications-the-plurality-of-inventions-debate-in-india[5] https://www.iam-media.com/review/the-patent-prosecution-review/2024/article/israel-deep-dive-national-prosecution-processes[6] https://www.managingip.com/article/2c6zuwss3s78xp9byrr40/expert-analysis/special-focus/divisional-patent-applications-in-india-the-power-of-a-comma Source

    Innovative Approaches to Extend the Life of Drug Patents

    Play Episode Listen Later Jun 17, 2024


    Pharmaceutical companies employ various strategies to extend the commercial life and patent protection of successful drugs. Here are some key approaches with examples: New Formulations One common strategy is to develop and patent new formulations of the existing drug compound to provide benefits like reduced dosing frequency, easier administration, improved bioavailability, or reduced side effects. […] Source

    How long does a patent last for drugs?

    Play Episode Listen Later Jun 12, 2024


    Sure, here's a more detailed explanation with examples: Drug Patent Duration Drug patents are granted by the United States Patent and Trademark Office (USPTO) for a period of 20 years… Source

    Crucial Insights on Patent Litigation Strategies in Pharma Industry

    Play Episode Listen Later Jun 10, 2024


    In the “Patent Effect” podcast, Mustafa introduces his guest, Hakan Yum, the IP Director of Exrain Pharma, based in Sweden. The focus of the discussion is on patent litigation strategies… Source

    Underutilized Opportunities: Exploring Patent Term Extensions for Medical Devices

    Play Episode Listen Later Jun 6, 2024


    In a recent study published in the Expert Review of Medical Devices, researchers investigated the utilization of patent term extensions (PTEs) to extend regulatory timeframes for medical devices in the… Source

    Innovative Strategies in Drug Repurposing

    Play Episode Listen Later Apr 23, 2024


    Drug repurposing, or identifying new therapeutic uses for existing drugs, is gaining significant momentum as a promising approach to accelerate drug development and reduce costs. This book chapter provides a… Source

    AI-Driven Drug Discovery: Transforming the Landscape of Pharmaceutical Research

    Play Episode Listen Later Apr 16, 2024


    The pharmaceutical industry in China is undergoing a significant transformation with the adoption of artificial intelligence (AI) technology. A recent study published in the Future Journal of Pharmaceutical Sciences evaluates… Source

    Innovative Financing Models for Repurposing Generic Drugs

    Play Episode Listen Later Apr 11, 2024


    A paper presented at the 2nd International Conference on Systems Medicine, AI, and Drug Repurposing proposes a novel approach to overcoming the financial barriers associated with repurposing generic drugs through… Source

    Biosimilar Competition Does Not Reduce Patient Out-of-Pocket Costs for Biologic Drugs

    Play Episode Listen Later Mar 31, 2024


    A recent study published in JAMA Health Forum sheds light on the impact of biosimilar competition on patient out-of-pocket (OOP) costs for biologic drugs in the United States. The research,… Source

    Unleashing Innovation: The Case for Permissionless R&D in Pharma

    Play Episode Listen Later Mar 22, 2024


    A recent article in Communications of the ACM explores opportunities for “Permissionless innovation” in pharmaceuticals. “Permissionless innovation” refers to the freedom to explore new technologies or businesses without needing prior… Source

    LACTOSE-Free Medicines: Which Drugs Contain LACTOSE?

    Play Episode Listen Later Mar 8, 2024


    LACTOSE-Free Medicines, 2024 is part of DrugPatentWatch's deep library of business intelligence on biopharmaceutical drugs. Buy Lactose-Free Medicines from Amazon This guide is designed to provide information for healthcare providers to… Source

    Claim DrugPatentWatch – Make Better Decisions

    In order to claim this podcast we'll send an email to with a verification link. Simply click the link and you will be able to edit tags, request a refresh, and other features to take control of your podcast page!

    Claim Cancel